Skip to main content

and
  1. Article

    Open Access

    Efficacy confirmation study of aceneuramic acid administration for GNE myopathy in Japan

    A rare muscle disease, GNE myopathy is caused by mutations in the GNE gene involved in sialic acid biosynthesis. Our recent phase II/III study has indicated that oral administration of aceneuramic acid to patient...

    Madoka Mori-Yoshimura, Naoki Suzuki, Masahisa Katsuno in Orphanet Journal of Rare Diseases (2023)

  2. Article

    Open Access

    Controlling nutritional status score during hospitalization as a predictor of clinical outcome in patients with aneurysmal subarachnoid hemorrhage

    Aneurysmal subarachnoid hemorrhage (aSAH) is a serious condition with high mortality and a high permanent disability rate. In this study, we examined the association of clinical outcome with the Controlling Nu...

    Shinya Shimizu, Tatsunori Hanai, Yusuke Egashira, Yukina Sato in Scientific Reports (2023)

  3. No Access

    Article

    The evaluation of the safety and efficacy of intravenously administered allogeneic multilineage-differentiating stress-enduring cells in a swine hepatectomy model

    Multilineage-differentiating stress-enduring (Muse) cells are non-tumorigenic endogenous pluripotent-like cells residing in the bone marrow that exert a tissue reparative effect by replacing damaged/apoptotic ...

    Masahiro Iseki, Masamichi Mizuma, Shohei Wakao, Yoshihiro Kushida in Surgery Today (2021)

  4. Article

    Open Access

    lncRNA transcription induces meiotic recombination through chromatin remodelling in fission yeast

    Noncoding RNAs (ncRNAs) are involved in various biological processes, including gene expression, development, and disease. Here, we identify a novel consensus sequence of a cis-element involved in long ncRNA (lnc...

    Satoshi Senmatsu, Ryuta Asada, Arisa Oda, Charles S. Hoffman in Communications Biology (2021)

  5. No Access

    Article

    Phase I study of brentuximab vedotin (SGN-35) in Japanese children with relapsed or refractory CD30-positive Hodgkin’s lymphoma or systemic anaplastic large cell lymphoma

    Data on the treatment of pediatric patients with brentuximab vedotin are limited. The aims of the present study were to assess the safety and tolerability of brentuximab vedotin in Japanese children with relap...

    Yuhki Koga, Masahiro Sekimizu, Akihiro Iguchi in International Journal of Hematology (2020)

  6. Article

    Open Access

    The impact of sirolimus therapy on lesion size, clinical symptoms, and quality of life of patients with lymphatic anomalies

    Lymphatic anomalies (LAs) include several disorders in which abnormal lymphatic tissue invades the neck, chest, and various organs. Progressive cases may result in lethal outcomes and have proven difficult to ...

    Michio Ozeki, Akifumi Nozawa, Shiho Yasue, Saori Endo in Orphanet Journal of Rare Diseases (2019)

  7. Article

    Open Access

    lncRNA transcriptional initiation induces chromatin remodeling within a limited range in the fission yeast fbp1 promoter

    Long noncoding RNAs (lncRNAs) transcribed across gene promoters have been detected. These regulate transcription by mechanisms that have not been fully elucidated. We herein show that the chromatin configurati...

    Satoshi Senmatsu, Ryuta Asada, Takuya Abe, Charles S. Hoffman in Scientific Reports (2019)

  8. Article

    Open Access

    Safety and Plasma Concentrations of a Cyclin-dependent Kinase 9 (CDK9) Inhibitor, FIT039, Administered by a Single Adhesive Skin Patch Applied on Normal Skin and Cutaneous Warts

    Cutaneous warts are caused by human papilloma virus (HPV) infection. FIT039, a specific inhibitor of CDK9, suppresses the proliferation of DNA viruses in vitro.

    Eriko Sumi, Takashi Nomura, Ryuta Asada, Ryuji Uozumi in Clinical Drug Investigation (2019)

  9. Article

    Open Access

    Phase I clinical trial results of aceneuramic acid for GNE myopathy in Japan

    GNE myopathy (distal myopathy with rimmed vacuoles) is a rare intractable muscle disease caused by the mutations in GNE gene, with no therapeutic agents at present. The mutations in GNE (UDP-N-acetylglucosamine 2...

    Naoki Suzuki, Masaaki Kato, Hitoshi Warita in Translational Medicine Communications (2018)

  10. Article

    Open Access

    A pilot study of regenerative therapy using controlled release of recombinant human fibroblast growth factor for patients with pre-collapse osteonecrosis of the femoral head

    We evaluated the safety and clinical outcomes of a single local administration of gelatin hydrogel impregnated with recombinant human fibroblast growth factor (rhFGF)-2 for the treatment of the precollapse sta...

    Yutaka Kuroda, Ryuta Asada, Kazutaka So, Atsushi Yonezawa in International Orthopaedics (2016)